Synthesis of non-GMP small molecules - incrementally funded
Active Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,249,540
Award facts
- Contract value 54% obligated
-
- $1,249,540.00 Current, with exercised options
- $2,332,902.00 Potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $315,000 | |
| Exercise an Option | $45,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $45,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $327,540 | |
| Supplemental Agreement for work within scope | $212,000 | |
| Original award | $305,000 |
About this award
The National Cancer Institute issued a delivery order to Alchem Laboratories Corporation on June 5, 2022, with a ceiling value of $2,332,902 for synthesis of non-GMP small molecules and cGMP synthesis of small molecules for drug development. The order is set aside for small business and carries a cost-plus-fixed-fee pricing structure.
Place of performance is Alachua, FL. The ultimate completion date is June 4, 2027. The work encompasses incremental synthesis of non-GMP small molecule samples and cGMP manufacturing of small molecules to support the National Cancer Institute's drug development pipeline.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on June 5, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $1,249,540 on 75N91022F00001. Its potential value, with all options, is $2,332,902.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under HHSN261201700007I, an indefinite delivery contract.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition after exclusion of sources. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award